See more : Savencia SA (SAVE.PA) Income Statement Analysis – Financial Results
Complete financial analysis of Digipath, Inc. (DIGP) income statement, including revenue, profit margins, EPS and key performance metrics. Get detailed insights into the financial performance of Digipath, Inc., a leading company in the Medical – Diagnostics & Research industry within the Healthcare sector.
You may be interested
- Real Estate Split Corp. (RS.TO) Income Statement Analysis – Financial Results
- Body and Mind Inc. (BAMM.CN) Income Statement Analysis – Financial Results
- Gruma, S.A.B. de C.V. (GRUMAB.MX) Income Statement Analysis – Financial Results
- Satellos Bioscience Inc. (MSCLF) Income Statement Analysis – Financial Results
- Kotobukiya Co., Ltd. (7809.T) Income Statement Analysis – Financial Results
Digipath, Inc. (DIGP)
About Digipath, Inc.
Digipath, Inc., together with its subsidiaries, provides cannabis and hemp lab testing services in Las Vegas to Nevada licensed medical marijuana enterprises. It also provides testing, cannabis education and training, and cannabis news coverage to the cannabis industry. The company operates as a testing laboratory facility for cannabis, cannabis infused products, hemp, and other botanical nutraceuticals to serve growers, dispensaries, caregivers, producers, patients, and end users of cannabis and botanical products. In addition, its labs screen medicinal and recreational cannabis for potentially harmful contaminants, including residual solvents; moisture; water activity; visual inspection; pesticides; heavy metals, such as mercury, arsenic, lead, cadmium, chromium, and nickel; biological toxins comprising aflatoxin and ocratoxins; and microbial contaminants consisting of E. coli, salmonella, coliforms, aspergillus, gram negative bacteria, total aerobic bacteria, and mold and yeast. Digipath, Inc. was incorporated in 2010 and is headquartered in Las Vegas, Nevada.
| Metric | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | 0.00 | 2.70M | 2.50M | 2.57M | 2.55M | 2.84M | 1.90M | 818.58K | 16.08K | 485.87K | 567.19K | 391.70K | 95.91K |
| Cost of Revenue | 0.00 | 1.63M | 1.79M | 1.78M | 1.71M | 2.07M | 904.17K | 380.04K | 85.55K | 297.53K | 303.95K | 222.22K | 0.00 |
| Gross Profit | 0.00 | 1.07M | 715.17K | 795.84K | 839.81K | 770.08K | 994.01K | 438.55K | -69.47K | 188.34K | 263.24K | 169.48K | 95.91K |
| Gross Profit Ratio | 0.00% | 39.48% | 28.56% | 30.91% | 32.90% | 27.12% | 52.37% | 53.57% | -431.90% | 38.76% | 46.41% | 43.27% | 100.00% |
| Research & Development | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 143.77K | 1.03K | 0.00 | 0.00 | 0.00 |
| General & Administrative | 437.39K | 2.02M | 1.52M | 2.27M | 2.55M | 2.55M | 2.26M | 2.80M | 3.23M | 3.01M | 574.82K | 0.00 | 113.03K |
| Selling & Marketing | -175.00K | 58.74K | 28.07K | 45.12K | 221.98K | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| SG&A | 262.39K | 2.02M | 1.52M | 2.27M | 2.55M | 2.55M | 2.26M | 2.80M | 3.23M | 3.01M | 574.82K | 479.15K | 113.03K |
| Other Expenses | 0.00 | -782.50K | 7.58K | 79.29K | 113.40K | 105.11K | 42.18K | 518.96K | 0.00 | 0.00 | 0.00 | 479.15K | 0.00 |
| Operating Expenses | 262.39K | 2.02M | 1.52M | 2.27M | 2.55M | 2.55M | 2.30M | 3.32M | 3.37M | 3.01M | 574.82K | 479.15K | 113.03K |
| Cost & Expenses | 262.39K | 3.65M | 3.30M | 4.04M | 4.27M | 4.62M | 3.21M | 3.70M | 3.46M | 3.31M | 878.78K | 701.37K | 113.03K |
| Interest Income | 0.00 | 260.27K | 929.00 | 148.02K | 65.67K | 0.00 | 10.00K | 10.00K | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Interest Expense | 364.27K | 260.27K | 144.96K | 148.02K | 65.67K | 0.00 | 0.00 | 0.00 | 0.00 | 11.64K | 18.06K | 16.02K | 10.43K |
| Depreciation & Amortization | 204.15K | 204.15K | 292.13K | 323.39K | 260.65K | 277.29K | 253.54K | 244.58K | 83.73K | 4.59K | 27.21K | 33.11K | 1.84K |
| EBITDA | -262.39K | -1.93M | -480.32K | -1.47M | -1.49M | -1.48M | -1.04M | -2.64M | -3.36M | -2.33M | -284.37K | -276.56K | -15.28K |
| EBITDA Ratio | 0.00% | -56.60% | -20.27% | -41.47% | -52.43% | -53.38% | -67.74% | -342.55% | -20,876.21% | -579.57% | -50.14% | -70.60% | -15.93% |
| Operating Income | -262.39K | -949.92K | -800.61K | -1.47M | -1.71M | -1.76M | -1.31M | -2.88M | -3.44M | -2.82M | -311.58K | -309.67K | -17.12K |
| Operating Income Ratio | 0.00% | -35.18% | -31.98% | -57.11% | -67.09% | -61.93% | -68.87% | -352.13% | -21,396.75% | -580.52% | -54.93% | -79.06% | -17.85% |
| Total Other Income/Expenses | -419.27K | -1.23M | 85.95K | -709.73K | -57.19K | 105.11K | 232.07K | -816.55K | -272.30K | -11.64K | -18.06K | -16.02K | -10.43K |
| Income Before Tax | -681.66K | -2.06M | -686.50K | -2.31M | -1.81M | -1.65M | -1.07M | -3.70M | -3.71M | -2.83M | -329.65K | -325.69K | -27.55K |
| Income Before Tax Ratio | 0.00% | -76.19% | -27.42% | -89.71% | -70.73% | -58.23% | -56.11% | -451.88% | -23,089.76% | -582.91% | -58.12% | -83.15% | -28.72% |
| Income Tax Expense | -928.43K | 64.43K | 144.96K | 227.31K | 179.07K | 105.11K | -242.07K | -176.13K | 618.57K | 0.00 | 0.00 | 0.00 | 0.00 |
| Net Income | 246.77K | -2.12M | -831.46K | -2.54M | -1.98M | -1.65M | -1.07M | -3.70M | -4.33M | -2.83M | -329.65K | -325.69K | -27.55K |
| Net Income Ratio | 0.00% | -78.58% | -33.21% | -98.54% | -77.74% | -58.23% | -56.11% | -451.88% | -26,935.64% | -582.91% | -58.12% | -83.15% | -28.72% |
| EPS | 0.00 | -0.03 | -0.01 | -0.05 | -0.04 | -0.04 | -0.04 | -0.20 | -0.44 | -1.16 | -0.60 | -0.60 | -0.05 |
| EPS Diluted | 0.00 | -0.03 | -0.01 | -0.05 | -0.04 | -0.04 | -0.04 | -0.20 | -0.44 | -1.16 | -0.60 | -0.60 | -0.05 |
| Weighted Avg Shares Out | 83.93M | 74.17M | 65.87M | 53.46M | 46.18M | 39.08M | 29.32M | 18.44M | 9.91M | 2.45M | 553.14K | 547.21K | 519.24K |
| Weighted Avg Shares Out (Dil) | 83.93M | 74.17M | 65.87M | 53.46M | 46.18M | 39.08M | 29.32M | 18.44M | 9.91M | 2.45M | 553.14K | 547.21K | 519.24K |
Digipath Name and Symbol Change Approved, Company Begins Trading as Hypha Labs, Inc. (FUNI)
LAS VEGAS, NV / ACCESSWIRE / August 13, 2024 / Hypha Labs, Inc. formerly (OTC PINK:DIGP), has been approved to commence trading as Hypha Labs, Inc. (OTC PINK:FUNI) on August 13, 2024. Hypha Labs has developed the first in-home mushroom...
Hypha Labs' Revolutionary Psilocybin Bioreactor Nominated for Best New Product of 2024 by Santa Monica Daily Press
LAS VEGAS, NV / ACCESSWIRE / July 31, 2024 / Hypha Labs, Inc. (OTC PINK:DIGP), a pioneer in functional mushroom sciences, is pleased to announce that the Company's proprietary bioreactor which allows individuals and companies to produce specialized mushroom ingredients...
CORRECTION: Hypha Laboratories Reveals New Patent Applications for Novel Artificial Intelligence (A.I.) Driven In-Home Mycelium Production
This release contains corrected contact information. Company Intends to Bring First Functional Mushroom Producer to Retail LAS VEGAS, NV / ACCESSWIRE / July 19, 2024 / Hypha Labs, Inc. (OTC PINK:DIGP), a pioneer in functional mushroom sciences, is pleased to...
CORRECTION: Hypha Laboratories Retains Integrity Media for Investor Relations and Corporate Communications
This release contains corrected contact information. Veteran Agency Brings Twenty-Five Years of Experience and Relationships to Emerging Functional Mushroom Science Company LAS VEGAS, NV / ACCESSWIRE / July 19, 2024 / Hypha Labs, Inc. (OTC PINK:DIGP), a pioneer in functional...
Hypha Laboratories Reveals New Patent Applications for Novel Artificial Intelligence (A.I.) Driven In-Home Mycelium Production
Company Intends to Bring First Functional Mushroom Producer to Retail LAS VEGAS, NV / ACCESSWIRE / June 24, 2024 / Hypha Labs, Inc. (OTC PINK:DIGP), a pioneer in functional mushroom sciences, is pleased to announce the addition of significant mycological...
Hypha Laboratories Retains Integrity Media for Investor Relations and Corporate Communications
Veteran Agency Brings Twenty-Five Years of Experience and Relationships to Emerging Functional Mushroom Science Company LAS VEGAS, NV / ACCESSWIRE / June 11, 2024 / Hypha Labs, Inc. (OTC PINK:DIGP), a pioneer in functional mushroom sciences, is pleased to announce...
Hypha Labs Names Craig Ellins Chief Science Officer
LAS VEGAS, NV / ACCESSWIRE / April 29, 2024 / Hypha Labs, Inc. (OTC Pink:DIGP) has announced that it has made Craig Ellins its Chief Science Officer. Hypha Labs, Inc. changed its name from Digipath, Inc. after the sale of...
Digipath Enters Psilocybin Industry and Changes Name
LAS VEGAS, NV / ACCESSWIRE / April 22, 2024 / Hypha Labs, Inc. (OTC PINK:DIGP) has announced that it has changed its name from Digipath, Inc. after the sale of its cannabis lab assets. In a change of direction, it...
Hypha Labs, Inc. to Present at the Planet MicroCap Showcase: VEGAS 2024 on Wednesday, May 1, 2024 & 1x1 Meetings on Thursday, May 2, 2024
LAS VEGAS, NV / ACCESSWIRE / March 18, 2024 / Hypha Labs, Inc. (OTC Pink:DIGP), short company description, today announced that it will be presenting at the Planet MicroCap Showcase: VEGAS 2024 on Wednesday, May 1, 2024 at 3 PST)....
Digipath Announces Record Earnings of $292,533 for Recent Quarter Ended June 30
Lab Operations has Seen a Consistent Uptick in Sample Flow LAS VEGAS, NV, Aug. 29, 2023 (GLOBE NEWSWIRE) -- via NewMediaWire - Digipath, Inc. (OTCQB: DIGP) (“DIGP” or the “Company”), a service-oriented independent analytical testing laboratory, focused on the cannabis and...
Source: https://incomestatements.info
Category: Stock Reports